4,732
Participants
Start Date
January 16, 2017
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Clinical outcomes
Clinical outcomes
Yale University, New Haven
Michigan State University, Lansing
Mayo Clinic, Rochester
University of North Carolina - Lineberger Comprehensive Cancer Center, Chapel Hill
Cleveland Clinic Taussig Cancer Institute, Cleveland
Lifespan Cancer Institute, Providence
Hospital Aleman, Buenos Aires
Hospital Italiano de Buenos Aires, Buenos Aires
Instituto Alexander Fleming, Buenos Aires
kConFab, Follow-up Project, Melbourne
Peter MacCallum Cancer Centre, Melbourne
Medical University of Vienna, Vienna
Cliniques Universitaires Saint-Luc UCL, Brussels
Institut Jules Bordet, Brussels
University Hospitals Leuven, KU Leuven, Leuven
Clinical Center University of Sarajevo, Sarajevo
Hospital Sírio-Libanês, Brasília
Cancer Institute ICESP, São Paulo
Mc Gill University, Montreal
Bergonie Institute, Bordeaux
Leon Berard Cancer Center, Lyon
Hopital Saint Louis, Paris
Institut Curie, Paris
Centre Henri Becquerel, Rouen
Institut Gustave Roussy, Villejuif
Todua Clinic, Tbilisi
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Leitung, Brustzentrum der Universität München (LMU), München
Tata Memorial Centre, Mumbai
Sharett Institute of Oncology - Hadassah Hebrew University Medical Center, Jerusalem
Davidoff Cancer Center - Rabin Medical Center - Beilinson, Petah Tikva
Sheba Medical Center, Tel Aviv
Tel Aviv Sourasky Medical Center, Tel Aviv
Università Politecnica delle Marche - Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I - GM Lancisi - G Salesi, Ancona
Oncological Center CRO, Aviano
"Azienda Ospedaliera Papa Giovanni XXIII", Bergamo
Azienda Ospedaliero Universitaria di Cagliari, Cagliari
Candiolo Cancer Center (IRCCS), Candiolo
Florence University Hospital - University of Florence, Florence
IRCCS Ospedale Policlinico San Martino, Genova
Azienda USL Toscana Sud Est - Misericordia Hospital, Grosseto
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola
European Institute of Oncology, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
IRCCS Ospedale San Raffaele, Milan
Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Modena
San Gerardo Hospital ASST Monza, Monza
"University of Naples Federico II", Naples
IOV (Istituto Oncologico Veneto), Padua
IRCCS Policlinico San Matteo, Pavia
Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara, Pisa
Nuovo Ospedale di Prato - Santo Stefano, Prato
AOU Policlinico Umberto I, Roma
ASL Roma 1 - Centro Oncologico S. Spirito - Nuovo Regina Margherita, Rome
Policlinico Universitario Agostino Gemelli IRCCS, Rome
Saint Joseph University of Beirut, Beirut
Instituto Nacional de Cancerologia, Mexico City
Hospital Zambrano Hellion - Tecnologico de Monterrey, Monterrey
Netherlands Cancer Institute, Amsterdam
Medical University of Gdansk, Gdansk
Poznan University of Medical Sciences, University Hospital of H. Swiecicki, Poznan
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw
Military institute of Medicine, Warsaw
Champalimaud Foundation, Lisbon
Hospital de Santa Maria and Instituto de Medicina Molecular of the Faculty of Medicine of the University of Lisbon, Lisbon
"Institute of Oncology Ion Chiricuta", Cluj-Napoca
Institute for Oncology and Radiology of Serbia, Belgrade
Oncology Institute of Vojvodina - University of Novi Sad, Novi Sad
St. Elisabeth Cancer Institute (Onkologicky ustav sv. Alzbety-OUSA), Bratislava
University of Ulsan, College of Medicine, Asan medical center, Seoul
Hospital Clínic of Barcelona, Barcelona
Vall D'Hebron University Hospital, Barcelona
Hospital Universitario 12 de Octubre, Madrid
Ramon y Cajal - IOB Institute of Oncology (Madrid) - International Breast Cancer Center (IBCC), Madrid
Hospital Universitari Son Espases Palma, Palma de Mallorca
INCLIVA, University Hospital of Valencia, Valencia
Capio Saint Göran's Hospital, Stockholm
Karolinska University Hospital, Stockholm
Stockholm Southern Hospital (Södersjukhuset), Stockholm
Oncology Institute of Southern Switzerland, Lugano
Dana-Farber Cancer Institute, Boston
Lead Sponsor
Jules Bordet Institute
OTHER